ARMISTICE CAPITAL LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-27 6:02 pm Sale | 2023-06-26 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 2,597 4.990% | -17,331 (-86.97%) | Filing |
| 2023-02-09 4:27 pm Purchase | 2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 19,928 35.400% | 1,876 (+10.39%) | Filing |
| 2022-08-11 4:09 pm Sale | 2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 18,052 44.400% | -0 (-0.00%) | Filing |
| 2022-03-15 5:16 pm Purchase | 2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 18,052 44.500% | 408 (+2.31%) | Filing |
| 2022-01-19 6:41 pm Purchase | 2022-01-18 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 17,643 43.700% | 486 (+2.83%) | Filing |
| 2021-12-16 4:04 pm Unchanged | 2021-12-14 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 17,157 42.500% | 0 (Unchanged) | Filing |
| 2021-11-08 4:05 pm Unchanged | 2021-11-04 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 17,157 43.900% | 0 (Unchanged) | Filing |
| 2021-10-14 9:01 pm Purchase | 2021-10-14 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 17,157 43.900% | 143 (+0.84%) | Filing |
| 2021-09-17 3:04 pm Purchase | 2021-09-17 | 13D | Avalo Therapeutics, Inc. AVTX | ARMISTICE CAPITAL LLC | 17,014 43.900% | 17,014 (New Position) | Filing |